Skip to main content

Exagen Inc.

XGN
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001274737

In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Exagen Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of XGN: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders53530
Shares8.60M9.09M+488.5K (+5.7%)
Value$100.0M$73.0M−$27.0M (−27.0%)

New holders (7)

Institutions that held Exagen Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to XGN in Q1 2022
InstitutionSharesValue% of portfolio
Cooper Creek Partners Management LLC153,468$1.23M0.13%
Barclays PLC7,066$56.0K0.00%
Russell Investments Group, Ltd.3,439$27.0K0.00%
Amalgamated Bank1,395$11.0K0.00%
Amalgamated Financial Corp.1,395$11.0K0.00%
Nisa Investment Advisors, LLC800$6.00K0.00%
FMR LLC126$1.00K0.00%

Sold out (7)

Institutions that held Exagen Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of XGN in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Maven Securities LTD52,491$610.0K
Millennium Management LLC29,294$341.0K
Goldman Sachs Group Inc10,738$125.0K
Total Clarity Wealth Management, Inc.1,723$20.0K
Amplius Wealth Advisors, LLC497$5.00K
US Bancorp73$1.00K
Simplex Trading, LLC12$0